Clinical trial for ruxolitinib planned in fight against COVID-19
Treatment for rare blood cancers could temper cytokine storm in people with severe forms of the disease
Fujifilm tests favipiravir as COVID-19 treatment
What explains the non-respiratory symptoms seen in some COVID-19 patients?
Some patients experience neurological, cardiovascular, and intestinal symptoms after infection with SARS-CoV-2
Chemical outlook post COVID-19 is bleak
COVID-19 vaccines are moving toward clinical trials
Fujifilm tests favipiravir as a COVID-19 treatment
How industrial gas firms are meeting demand for medical oxygen for COVID-19 patients
Consortia lend their supercomputers to fight COVID-19
National labs, universities, and companies around the world are fast-tracking proposals to use their high-performance computer resources against the novel coronavirus
COVID-19 claims the life of beloved chemistry professor
NIH unveils consortium to tackle COVID-19 research
Multiple government agencies and pharma companies join the effort to develop therapeutics and vaccines
NIH unveils consortium to tackle COVID-19 research
Multiple government agencies and pharma companies join the effort to develop therapeutics and vaccines
How genomic epidemiology is tracking the spread of COVID-19 locally and globally
The novel coronavirus is challenging genome sequencing technology and data processing like never before
Bill Suits dies of COVID-19 complications
Clinical trials planned to put hydroxychloroquine to the test for COVID-19
The antimalaria drug will be tested for treating or preventing the disease in thousands of people worldwide
<i>Science</i> editor in chief Holden Thorp on the role of science during the COVID-19 pandemic
The chemist and former university administrator uses editorials to speak up for science during an ‘extraordinary' time
How ACS local sections are supporting their communities during COVID-19
ACS local sections and members are gathering lab equipment, making chemistry-themed face masks, and more to pitch in during the pandemic
COVID-19 is reshaping the pharmaceutical supply chain
The coronavirus pandemic may mark a rebalancing of where drugs are made as nations recognize a security imperative
Does the FDA's authorization for chloroquine impede clinical trials for COVID-19 drugs?
Despite the hype, support for the use of chloroquine and its relative hydroxychloroquine outside a clinical trial remains mixed
Gilead's remdesivir gets emergency use authorization based on preliminary data in COVID-19
Limited results from a NIAID study suggest the drug helps people with COVID-19 recover faster
Ying Kao Lee dies of COVID-19
An emerging antiviral takes aim at COVID-19
EIDD-2801 wasn't designed to fight the novel coronavirus, but its chemistry might make it an ideal weapon in this pandemic and the next
Lieng-Huang Lee dies of COVID-19
A COVID-19 diagnostic that uses CRISPR gets a nod from the FDA
Sherlock Biosciences' test becomes the first FDA-authorized CRISPR technology on the market
Computational researchers pledge openness in COVID-19 studies
Hundreds of researchers commit to sharing data and tools so they can better work together to understand and treat SARS-CoV-2
Covid-19: Legislation introduced in Congress to give Green Card to foreign nurses, doctors
Most employers keen to retain existing workforce amid COVID-19 crisis, says survey
AIIMS medical experts sent to Gujarat after sharp rise in coronavirus COVID-19 cases, fatalities
With Gujarat reporting a large number of coronavirus COVID-19 cases and fatalities, medical experts from AIIMS, including its director Dr Randeep Guleria, have rushed to Ahmedabad to provide expert guidance to doctors there on COVID-19 management.
714 police personnel infected with COVID-19 in Maharashtra; 194 cases of assault on cops during lockdown
As many as 98,774 cases were registered and 19,082 persons were arrested for violating prohibitory orders during the COVID-19 lockdown in the state.
Yogi Adityanath reviews COVID-19 situation in Uttar Pradesh
Uttar Pradesh Chief Minister Yogi Adityanath on Saturday (May 9) stressed on the need to understand the "chemistry of corona while administering its treatment".
COVID-19: HRD assessing situation in countries with CBSE schools to decide on pending board exams
The Central Board of Secondary Education (CBSE) had last month announced that it will not be conducting the pending exams in foreign countries. According to officials, HRD Minister Ramesh Pokhriyal 'Nishank' has sought feedback from representatives in different countries about the current situation there.